Advanced BioMedical Technologies, Inc. (ABMT)

0.0006 0.0000 (0.00%) At close: 12:15PM EDT

Advanced BioMedical Technologies, Inc.

200 Park Avenue
Suite 1700
New York, NY 10166
United States
718 766 7898
https://abtlafleur.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 17

Key Executives

Name	Title	Pay	Exercised	Year Born
Ms. Hui Wang	CEO, Controller & Director	34.6k	N/A	1970
Mr. Chi Ming Yu	President, Treasurer, Compliance Officer & Director	N/A	N/A	1974
Mr. Kai Gui	Secretary, CFO, COO & Director	N/A	N/A	1970
Prof. Puyi Sheng M.D., Ph.D.	Chief Medical Officer	N/A	N/A	1968
Prof. Shangli Liu M.D., Ph.D.	Chairman of Scientific Board & Chief Medical Advisor of Greater China	N/A	N/A	N/A
Dr. John Thomas Lynch Jr.	Chief Officer of Dental Technologies	N/A	N/A	N/A

Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.

Corporate Governance

Advanced BioMedical Technologies, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.